BRISBANE, Calif., May 9 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that Dan Welch, President and Chief Executive Officer of InterMune, will present at the Bank of America 2008 Health Care Conference in Las Vegas on May 14, 2008 at 9:20 a.m. PDT (12:20 p.m EDT).
Array BioPharma, Inc. (ARRY) Q3 2008 Earnings CallComplete Story » ... W. Baird & Co. Ian Somaiya – Thomas Weisel Partners Operator Good day everyone and welcome to today’s Array BioPharma quarterly conference call. Thanks for joining the call to discuss Array’s third...
Biotechnology company InterMune Inc. said Thursday its first-quarter loss widened on lower revenue from its immune-system disorder drug Actimmune. The company lost $26.3 million, or 68 cents per share, compared with a loss of $20.7 million, or 61 cents per share, during the same period a year...
BRISBANE, Calif., May 1 /PRNewswire-FirstCall/ -- Results from four dose cohorts in the important Phase 1b multiple-ascending-dose(MAD) study of ITMN-191 suggest a very competitive product profile for ITMN-191. The balance of this year and early 2009 will be a pivotal...
Phase Forward Reports First Quarter 2008 Results ... WALTHAM, Mass. --(Business Wire)-- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its financial results for the first...
BRISBANE, Calif., April 24 /PRNewswire-FirstCall/ - InterMune, Inc. announced today that it will release first quarter 2008 financial results on Thursday, ... ... BRISBANE, Calif., April 24 /PRNewswire-FirstCall/ -- InterMune, Inc. announced today that it will release...
InterMune has announced that it will initiate an open-label roll-over study to evaluate the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis. ... The roll-over study will be open to patients who complete one of the two concurrent Phase III...
The markets ended mixed today after a choppy session, but they did have a nice 3-wave rally in late morning to early afternoon that took the indices back from negative territory. But the semiconductor group, as we had indicated to our subscribers this weekend, may lead the market, and certainly...
Series B Round Gains $25M for Stromedix Fibrosis Trial ... Financings Roundup Stromedix Inc. said it has raised $25 million in a Series B financing round, money that will be used to support its fibrosis programs. Fibrosis, the formation of scar tissue due to injury or...
BUYINS.NET: BLG, BLDR, ITMN, RGRP, DPFD, AITP Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days ... BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold list for 13...